Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1985 4
1987 4
1988 2
1990 1
1991 1
1992 1
1993 4
1994 2
1995 5
1996 6
1997 7
1998 7
1999 8
2000 9
2001 4
2002 8
2003 9
2004 9
2005 7
2006 6
2007 10
2008 4
2009 10
2010 12
2011 10
2012 10
2013 20
2014 18
2015 12
2016 14
2017 13
2018 6
2019 9
2020 11
2021 17
2022 10
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Results by year

Filters applied: . Clear all
Page 1
GBA mutations, glucosylceramide and Parkinson's disease.
Milenkovic I, Blumenreich S, Futerman AH. Milenkovic I, et al. Among authors: futerman ah. Curr Opin Neurobiol. 2022 Feb;72:148-154. doi: 10.1016/j.conb.2021.11.004. Epub 2021 Dec 6. Curr Opin Neurobiol. 2022. PMID: 34883387 Review.
Mammalian ceramide synthases.
Levy M, Futerman AH. Levy M, et al. Among authors: futerman ah. IUBMB Life. 2010 May;62(5):347-56. doi: 10.1002/iub.319. IUBMB Life. 2010. PMID: 20222015 Free PMC article. Review.
A Stroll Down the CerS Lane.
Zelnik ID, Rozman B, Rosenfeld-Gur E, Ben-Dor S, Futerman AH. Zelnik ID, et al. Among authors: futerman ah. Adv Exp Med Biol. 2019;1159:49-63. doi: 10.1007/978-3-030-21162-2_4. Adv Exp Med Biol. 2019. PMID: 31502199 Review.
Neuronal forms of Gaucher disease.
Vitner EB, Futerman AH. Vitner EB, et al. Among authors: futerman ah. Handb Exp Pharmacol. 2013;(216):405-19. doi: 10.1007/978-3-7091-1511-4_20. Handb Exp Pharmacol. 2013. PMID: 23563668 Review.
Emerging therapeutic targets for Gaucher disease.
Vitner EB, Vardi A, Cox TM, Futerman AH. Vitner EB, et al. Among authors: futerman ah. Expert Opin Ther Targets. 2015 Mar;19(3):321-34. doi: 10.1517/14728222.2014.981530. Epub 2014 Nov 21. Expert Opin Ther Targets. 2015. PMID: 25416676 Review.
Making Sense of the Yeast Sphingolipid Pathway.
Megyeri M, Riezman H, Schuldiner M, Futerman AH. Megyeri M, et al. Among authors: futerman ah. J Mol Biol. 2016 Dec 4;428(24 Pt A):4765-4775. doi: 10.1016/j.jmb.2016.09.010. Epub 2016 Sep 21. J Mol Biol. 2016. PMID: 27664439 Review.
Animal models for Gaucher disease research.
Farfel-Becker T, Vitner EB, Futerman AH. Farfel-Becker T, et al. Among authors: futerman ah. Dis Model Mech. 2011 Nov;4(6):746-52. doi: 10.1242/dmm.008185. Epub 2011 Oct 4. Dis Model Mech. 2011. PMID: 21954067 Free PMC article. Review.
Glycosphingolipidoses: beyond the enzymatic defect.
Raas-Rothschild A, Pankova-Kholmyansky I, Kacher Y, Futerman AH. Raas-Rothschild A, et al. Among authors: futerman ah. Glycoconj J. 2004;21(6):295-304. doi: 10.1023/B:GLYC.0000046272.38480.ef. Glycoconj J. 2004. PMID: 15514478 Review.
268 results